SibEnzyme
Private Company
Funding information not available
Overview
SibEnzyme is a long-established, private Russian biotech firm operating as a specialized manufacturer and supplier of research-grade enzymes and molecular biology reagents. Founded in the scientific hub of Novosibirsk, it has developed a focused portfolio around restriction/modification enzymes and nucleic acid processing tools, catering primarily to the academic and industrial research markets. The company appears to be revenue-generating through direct sales of its catalog products, with a business model centered on enzymology and proteomics for research. Its strategic position is defined by niche expertise in enzymology rather than therapeutic or diagnostic development.
Technology Platform
Microbial enzymology platform for the discovery, production, and purification of restriction endonucleases, DNA polymerases, methyltransferases, nucleases, and nucleoside triphosphates (NTPs) for molecular biology research.
Opportunities
Risk Factors
Competitive Landscape
SibEnzyme competes in the global research enzymes market against dominant players like New England Biolabs, Thermo Fisher Scientific, and Merck. Its competitive edge lies in niche enzyme offerings, cost competitiveness, and strong regional presence in Russia and CIS markets, but it lacks the global distribution and brand recognition of its larger rivals.